AAAAAA

   
Results: 1-8 |
Results: 8
Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: Results of AIDS clinical trials group (ACTG) 401
Authors: Gerber, JG Rosenkranz, S Segal, Y Aberg, J D'Amico, R Mildvan, D Gulick, R Hughes, V Flexner, C Aweeka, F Hsu, A Gal, J
Citation: Jg. Gerber et al., Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: Results of AIDS clinical trials group (ACTG) 401, J ACQ IMM D, 27(2), 2001, pp. 153-160
Making the most of sparse clinical data by using a predictive-model-based analysis, illustrated with a stavudine pharmacokinetic study
Authors: Zhang, LP Price, R Aweeka, F Bellibas, SE Sheiner, LB
Citation: Lp. Zhang et al., Making the most of sparse clinical data by using a predictive-model-based analysis, illustrated with a stavudine pharmacokinetic study, EUR J PH SC, 12(4), 2001, pp. 377-385
Pharmacokinetics and pharmacodynamics of thalidomide in HIV patients treated for oral aphthous ulcers: ACTG protocol 251
Authors: Aweeka, F Trapnell, C Chernoff, M Jayewardene, A Spritzler, J Bellibas, SE Lizak, P Jacobson, J
Citation: F. Aweeka et al., Pharmacokinetics and pharmacodynamics of thalidomide in HIV patients treated for oral aphthous ulcers: ACTG protocol 251, J CLIN PHAR, 41(10), 2001, pp. 1091-1097
The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function
Authors: Aweeka, F Jayesekara, D Horton, M Swan, S Lambrecht, L Wilner, KD Sherwood, J Anziano, RJ Smolarek, TA Turncliff, RZ
Citation: F. Aweeka et al., The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function, BR J CL PH, 49, 2000, pp. 27S-33S
Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1-infected patients with and without AIDS dementia complex
Authors: Aweeka, F Jayewardene, A Staprans, S Bellibas, SE Kearney, B Lizak, P Novakovic-Agopian, T Price, RW
Citation: F. Aweeka et al., Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1-infected patients with and without AIDS dementia complex, J ACQ IMM D, 20(1), 1999, pp. 39-43
Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection
Authors: Staprans, S Marlowe, N Glidden, D Novakovic-Agopian, T Grant, RM Heyes, M Aweeka, F Deeks, S Price, RW
Citation: S. Staprans et al., Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection, AIDS, 13(9), 1999, pp. 1051-1061
Altered pharmacokinetics of indinavir by a novel nonnucleoside reverse transcriptase inhibitor (HBY-097): A pharmacokinetic evaluation in HIV-positive patients
Authors: Hayashi, S Jayesekera, D Jayewardene, A Shah, A Thevanayagam, L Aweeka, F
Citation: S. Hayashi et al., Altered pharmacokinetics of indinavir by a novel nonnucleoside reverse transcriptase inhibitor (HBY-097): A pharmacokinetic evaluation in HIV-positive patients, J CLIN PHAR, 39(10), 1999, pp. 1085-1093
High-performance liquid chromatographic determination of ribavirin in whole blood to assess disposition in erythrocytes
Authors: Homma, M Jayewardene, AL Gambertoglio, J Aweeka, F
Citation: M. Homma et al., High-performance liquid chromatographic determination of ribavirin in whole blood to assess disposition in erythrocytes, ANTIM AG CH, 43(11), 1999, pp. 2716-2719
Risultati: 1-8 |